Infinity Pharmaceuticals, Inc. (INFI) Social Stream
INFINITY PHARMACEUTICALS INC (INFI) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering INFINITY PHARMACEUTICALS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-10 | 7 | $14 | $4 | $9.285 | $0.045 | 20533.33% |
| 2022-01-06 | 7 | $14 | $7 | $9.714 | $0.045 | 21486.67% |
| 2022-01-21 | 7 | $14 | $5 | $9.428 | $0.045 | 20851.11% |
| 2022-03-30 | 6 | $14 | $5 | $9.428 | $0.045 | 20851.11% |
| 2022-03-31 | 7 | $14 | $4 | $7.166 | $0.045 | 15824.44% |
| 2022-05-04 | 6 | $14 | $4 | $6.8 | $0.045 | 15011.11% |
| 2022-05-23 | 4 | $14 | $3 | $6.5 | $0.045 | 14344.44% |
| 2022-08-10 | 3 | $4 | $3 | $3.333 | $0.045 | 7306.67% |
| 2022-11-14 | 2 | $4 | $3 | $3.5 | $0.045 | 7677.78% |
| 2022-11-16 | 3 | $4 | $1.5 | $2.833 | $0.045 | 6195.56% |
| 2023-02-23 | 1 | $0.3 | $0.3 | $0.3 | $0.045 | 566.67% |
Price Target Last Issued February 23, 2023
The Trend in the Analyst Price Target
Over the past 24 months, INFI's average price target has gone down $5.45.
INFI reports an average of 347.67% for its upside potential over the past 101 days.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-14 | 3 | 4.0 | 3.0 | 3.50 | 0.740 | 372.97% |
| 2022-11-14 | 2 | 4.0 | 3.0 | 3.50 | 0.740 | 372.97% |
| 2023-02-23 | 1 | 0.3 | 0.3 | 0.30 | 0.281 | 6.76% |
| 2023-02-23 | 2 | 0.3 | 0.3 | 0.30 | 0.281 | 6.76% |
| 2023-02-23 | 2 | 4.0 | 0.3 | 2.15 | 0.281 | 665.12% |
INFI Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3 | 0 | 0 | 1 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
INFI's average broker recommendation rating worsened by 2 over the prior 39 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how INFINITY PHARMACEUTICALS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1693.04% of that group.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, INFINITY PHARMACEUTICALS INC's average analyst price target is greater than 87.27% of them.
- In terms of how INFINITY PHARMACEUTICALS INC fares relative to stocks in the mid market cap category, note that its variance in analysts' estimates is lower than -1170.2% of that group.
- INFINITY PHARMACEUTICALS INC's number of analysts covering the stock is higher than 359.75% of stocks in the mid market cap category.
Stocks similar to INFINITY PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are INSM, CORT, and INVA.
View All Top Stocks by Price Target
Make investment decisions regarding INFI using the data that counts. Try POWR Ratings for free.